发明授权
- 专利标题： Ophthamological drugs
- 专利标题（中）： ophthamological drug
-
申请号： US12511861申请日： 2009-07-29
-
公开(公告)号： US08642644B2公开(公告)日： 2014-02-04
- 发明人: Eric J. Toone , David L. Epstein , Pratap Challa , Phillip W. Snyder , Xin Chen , Mitchell A. deLong
- 申请人： Eric J. Toone , David L. Epstein , Pratap Challa , Phillip W. Snyder , Xin Chen , Mitchell A. deLong
- 申请人地址： US NC Durham
- 专利权人： Duke University
- 当前专利权人： Duke University
- 当前专利权人地址： US NC Durham
- 代理机构： Michael Best & Friedrich LLP
- 主分类号： A01N43/12
- IPC分类号： A01N43/12 ; A01N43/06 ; A01N37/10 ; A61K9/00
摘要：
The present invention relates generally to ophthamological drugs. More specifically, the invention relates to a method of modifying (derivatizing) ophthamological drugs so as to increase their penetration through the cornea. The invention also relates to drugs modified (derivatized) in accordance with the instant method and to the use of same in treating conditions associated with elevated intraocular pressure, particularly, glaucoma.
公开/授权文献
- US20090318542A1 OPHTHAMOLOGICAL DRUGS 公开/授权日：2009-12-24
信息查询
IPC分类:
